CCCC

SEC source: 0001209191-21-055886 · doc4.xml · nonDerivative · entry 4

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By ERP Business Holdings, LP

Disclosed balance after: 588,223

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.

SEC source: 0001209191-21-055886 · doc4.xml · nonDerivative · entry 3

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 84,014

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-055886 · doc4.xml · nonDerivative · entry 2

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By ERP Business Holdings, LP

Disclosed balance after: 591,553

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.

SEC source: 0001209191-21-055886 · doc4.xml · nonDerivative · entry 1

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 87,344

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-055881 · doc4.xml · derivative · entry 3

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,321

Underlying: Common Stock · 12,500 shares

Expires 2030-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter.

SEC source: 0001209191-21-055881 · doc4.xml · nonDerivative · entry 2

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

SEC source: 0001209191-21-055881 · doc4.xml · nonDerivative · entry 1

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-053162 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,672

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.

SEC source: 0001209191-21-050057 · doc4.xml · nonDerivative · entry 1

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 88,574

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-050055 · doc4.xml · nonDerivative · entry 1

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,744

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-049118 · doc4.xml · nonDerivative · entry 2

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 102,981

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-049116 · doc4.xml · nonDerivative · entry 2

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,801

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-049120 · doc4.xml · derivative · entry 3

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,821

Underlying: Common Stock · 12,500 shares

Expires 2030-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter.

SEC source: 0001209191-21-049120 · doc4.xml · nonDerivative · entry 2

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

SEC source: 0001209191-21-049120 · doc4.xml · nonDerivative · entry 1

Siegel Jolie · CIK 0001768223 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-049118 · doc4.xml · nonDerivative · entry 1

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 107,238

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-049116 · doc4.xml · nonDerivative · entry 1

Fisher Stewart · CIK 0001824863 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,905

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.085. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-049114 · doc4.xml · derivative · entry 3

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,108

Underlying: Common Stock · 15,000 shares

Expires 2030-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020.

SEC source: 0001209191-21-049114 · doc4.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

SEC source: 0001209191-21-049114 · doc4.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-047169 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,427

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.

SEC source: 0001209191-21-045805 · doc4.xml · nonDerivative · entry 1

COHEN ALAIN J · CIK 0001132946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 517

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021.

F3 · balance_after: This amount has been adjusted to reflect 61,877 shares previously transferred from the Reporting Person to the Alain J. Cohen Revocable Trust.

SEC source: 0001209191-21-045807 · doc4.xml · nonDerivative · entry 1

COHEN MARC A · CIK 0001132945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,641

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021.

F3 · balance_after: This amount has been adjusted to reflect 92,817 shares previously transferred from the Reporting Person to the Marc Andrew Cohen Revocable Trust.

SEC source: 0001209191-21-045808 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,182

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021.

SEC source: 0001209191-21-045806 · doc4.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,366

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021.

SEC source: 0001209191-21-052780 · doc4.xml · nonDerivative · entry 1

Dubin Glenn · CIK 0001308597 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021.

SEC source: 0001209191-21-045691 · doc4.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,292

Underlying: Common Stock · 15,000 shares

Expires 2029-04-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

F3 · derivative.exercise_date: 25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter.

SEC source: 0001209191-21-045691 · doc4.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

SEC source: 0001209191-21-045691 · doc4.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,700

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.33 to $38.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

SEC source: 0001209191-21-045691 · doc4.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021.

SEC source: 0001209191-21-042299 · doc4.xml · derivative · entry 1

White Lauren · CIK 0001864430 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,000

Underlying: Common Stock · 136,000 shares

Expires 2031-06-20

F1 · derivative.exercise_date: 25% of this option shall vest and become exercisable on June 21, 2022, with the remainder vesting in 36 equal monthly installments thereafter.

SEC source: 0001209191-21-042300 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,843

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.

SEC source: 0001209191-21-041424 · doc4.xml · derivative · entry 1

COHEN ALAIN J · CIK 0001132946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,500

Underlying: Common Stock · 23,500 shares

Expires 2031-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

SEC source: 0001209191-21-041423 · doc4.xml · derivative · entry 1

COHEN MARC A · CIK 0001132945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,500

Underlying: Common Stock · 23,500 shares

Expires 2031-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

SEC source: 0001209191-21-041425 · doc4.xml · derivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,500

Underlying: Common Stock · 23,500 shares

Expires 2031-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

SEC source: 0001209191-21-041421 · doc4.xml · derivative · entry 1

DOWNEY BRUCE · CIK 0001237257 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,500

Underlying: Common Stock · 23,500 shares

Expires 2031-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

SEC source: 0001209191-21-041426 · doc4.xml · derivative · entry 1

Prokupets Elena · CIK 0001824823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,500

Underlying: Common Stock · 23,500 shares

Expires 2031-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

SEC source: 0001209191-21-041427 · doc4.xml · derivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,500

Underlying: Common Stock · 23,500 shares

Expires 2031-06-14

F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders.

SEC source: 0001209191-21-040277 · doc4.xml · nonDerivative · entry 2

COHEN ALAIN J · CIK 0001132946 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,741,930

F1 · kind: Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-040277 · doc4.xml · nonDerivative · entry 1

COHEN ALAIN J · CIK 0001132946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,143

F1 · kind: Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001209191-21-040278 · doc4.xml · nonDerivative · entry 2

COHEN MARC A · CIK 0001132945 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,874,805

F1 · kind: Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-21-040278 · doc4.xml · nonDerivative · entry 1

COHEN MARC A · CIK 0001132945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,936

F1 · kind: Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001209191-21-035501 · doc4.xml · nonDerivative · entry 1

Salter Malcolm · CIK 0001825124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,598

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.

SEC source: 0001209191-21-026665 · doc4.xml · derivative · entry 10

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,002

Underlying: Common Stock · 444 shares

Expires 2030-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Represents underlying unexercised options that were granted on July 3, 2020. The terms of the original grant provide that this option shall vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020.

SEC source: 0001209191-21-026665 · doc4.xml · derivative · entry 9

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

Underlying: Common Stock · 267 shares

Expires 2026-07-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.

SEC source: 0001209191-21-026665 · doc4.xml · nonDerivative · entry 4

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,146

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-026665 · doc4.xml · nonDerivative · entry 3

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,702

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-026665 · doc4.xml · nonDerivative · entry 2

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 47,316

F2 · shares: On April 13, 2021, Cynthia E. Anderson received a distribution of 2,278 shares of the Issuer's common stock from the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust.

SEC source: 0001209191-21-026665 · doc4.xml · nonDerivative · entry 1

Anderson Kenneth Carl · CIK 0001824862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,435

F1 · shares: On April 13, 2021, Kenneth C. Anderson received a distribution of 2,278 shares of the Issuer's common stock from the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust.

SEC source: 0001209191-21-025662 · doc4.xml · nonDerivative · entry 1

COHEN ALAIN J · CIK 0001132946 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266

F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.